KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
84 hedge funds and large institutions have $156M invested in Kindred Biosciences, Inc. in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% more funds holding
Funds holding: 82 → 84 (+2)
Holders
84
Holding in Top 10
–
Calls
$1.19M
Puts
$599K
Top Buyers
| 1 | +$19.1M | |
| 2 | +$4.43M | |
| 3 | +$1.58M | |
| 4 |
HM
HealthCor Management
New York
|
+$1.32M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.08M |
Top Sellers
| 1 | -$3.83M | |
| 2 | -$3.73M | |
| 3 | -$1.06M | |
| 4 |
Renaissance Technologies
New York
|
-$860K |
| 5 |
Morgan Stanley
New York
|
-$466K |